<DOC>
	<DOCNO>NCT00222794</DOCNO>
	<brief_summary>This study propose examine effect atomoxetine quality life negative symptom social withdrawal , lack interest thing , lack thought content , flat emotion , slow body movement lack drive motivation patient schizophrenia schizoaffective disorder . This study also examine safety use atomoxetine along conventional antipsychotic patient .</brief_summary>
	<brief_title>A Clinical Trial Examine Effects Atomoxetine Treatment Negative Symptoms Patients With Schizophrenia</brief_title>
	<detailed_description>This study propose examine effect Atomoxetine ( Strattera ) , selective norepinephrine reuptake inhibitor Negative Symptoms Quality Life safety use conjunction atypical antipsychotic agent remit community dwell subject Schizophrenia Schizoaffective disorder . Atomoxetine recently approve FDA treatment Attention Deficit Hyperactivity Disorder child adult . All subject receive various psychometric assessment 2-week interval period 26 week . It hypothesize subject treat Atomoxetine 26 week random assignment , parallel-group , double-blind , placebo-controlled study , significantly great improvement quality life social functioning .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Male female . Ages 1865 year inclusive . No psychiatric hospitalization past 30 day . Diagnostic Statistical Manual Mental Disorders ( DSM ) diagnosis schizophrenia . Total Positive Negative Syndrome Scale ( PANSS ) score 80 less entry . Currently receive stable dose antipsychotic ( ) least 30 day prior randomization . Receiving stable dose psychotropic medication least 30 day Female patient childbearing age must use acceptable method birth control . A minimum score 10 five global rating Scale Assessment Negative Symptoms ( SANS ) minimum score least 3 two global item mean score 4 less General Life Satisfaction Lehman 's quality life ( QOL ) interview . Inability give inform consent . Current alcohol substance abuse dependence within last 6 month . History narrow angle glaucoma organic brain disease . Female patient childbearing potential without adequate contraception . Uncontrolled diabetes mellitus ( fast blood glucose &gt; 126mg/dL ) , uncontrolled hypertension ( systolic &gt; 160mm/hg diastolic &gt; 100mm/hg ) orthostatic hypotension , assess case case basis , liver disease ( AST &gt; 40 u/L , ALT &gt; 56 u/L ) , cerebrovascular disorder myocardial infarction diagnose 3 month prior study entry . Concurrently receive treatment venlafaxine ( Effexor ) , MAO inhibitor Nardil ( phenelzine ) , Parnate ( tranylcypromine ) , cytochrome p450 2d6 inhibitor fluoxetine ( Prozac , Sarafem ) , paroxetine ( Paxil ) , quinidine ( Cardioquin , Quinidex Extentabs ) , albuterol ( Ventolin , Proventil , Combivent , AccuNeb , Serevent ) psychostimulants ( dextroamphetamine methylphenidate ) currently within last 2 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizo-Affective Disorder</keyword>
	<keyword>Negative Symptoms</keyword>
	<keyword>Atomoxetine</keyword>
	<keyword>Strattera</keyword>
</DOC>